Blog

Philadelphia’s Startup Ecosystem Climbs 15 Spots Into the Top 30 Worldwide, Report Says

September 22, 2021

Philadelphia’s startup ecosystem ranks among the best in the world, reaching No. 28 globally, according to the latest report from research firm Startup Genome. Startup Genome’s Global Startup Ecosystem Report ranked more than 275 regional ecosystems based on factors like startup growth and activity, innovation and research, capital availability, talent and support for companies. Silicon […]

Navrogen Enters Into CRADA With USAMRIID To Test Proprietary Small Molecule NK Cell Activators Against SARS-COV-2 Infection

September 16, 2021

Navrogen, Inc., a privately held preclinical biotechnology company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with researchers at The United States Army Medical Research Institute of Infectious Diseases (USAMRIID). The CRADA is focused on testing Navrogen’s small molecule NK cell activating agents on suppressing propagation of SARS-COV-2. Researchers […]

Morgan Berman is Leaving Milkcrate as CEO to Run a Nonprofit. Here’s Why

September 13, 2021

Since launching locally in December 2019, Life Science Cares Philadelphia (LSC) has become known for connecting life sciences companies to poverty-reducing causes. With its former executive director Pete Wolf retiring, the nonprofit has found a new ED in entrepreneur Morgan Berman. Yes — that’s MilkCrate CEO and outspoken social entrepreneurship advocate Morgan Berman. And yes, […]

RecoveryLink and 2 More Startups Got Investments From Penn’s New $5M Fund for Health

September 7, 2021

Two-year-old telehealth company RecoveryLink is one of three tech startups to receive funding from the Fund for Health, a new partnership between Penn Medicine and the Wharton Social Impact Initiative. Over the next three years, the Fund will invest $5 million in early-stage businesses addressing the social determinants of the health of economically disadvantaged Philadelphians. […]

Navrogen Raises $3M in Venture Capital Financing to Advance Cancer Therapy Platform

September 3, 2021

A 4-year-old biotechnology company based on the campus of Cheyney University of Pennsylvania has raised $3 million in a venture capital financing. Navrogen Inc. plans to use the proceeds from the seed funding round to support its technology platform being used to develop potential new therapies targeting immunosuppressed cancers and immune-mediated diseases. The financing was […]